Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy
Sign Up to like & getrecommendations! Published in 2021 at "Brazilian Journal of Pharmaceutical Sciences"
DOI: 10.1590/s2175-97902020000419078
Abstract: 1,5-Anhydroglucitol (1,5-AG) is a non-fasting glycemic marker that responds to hyperglycemia excursions. The reduction in serum levels of 1,5-AG is associated with an increase in postprandial glycemia and glycosuria, phenomena that increase the risk and… read more here.
Keywords: patients without; serum; type diabetes; anhydroglucitol ... See more keywords